Core Viewpoint - The announcement details a capital injection agreement by Baiguoyuan Group, where two individuals will invest in the company, resulting in a dilution of the company's ownership stake in its subsidiary [1] Group 1: Capital Injection Agreement - Baiguoyuan Group has entered into a capital injection agreement on February 2, 2026, with Tian Xiqiu and Lai Xianyang agreeing to invest in Baiguoyuan Commercial Management at a price of RMB 1.0 per share [1] - Tian Xiqiu will contribute RMB 660,000 and Lai Xianyang will contribute RMB 300,000 in cash to the registered capital of Baiguoyuan Commercial Management [1] - After the completion of the capital injection, Tian Xiqiu and Lai Xianyang will hold approximately 33.67% and 15.31% of the equity in Baiguoyuan Commercial Management, respectively [1] Group 2: Ownership Structure - Following the capital injection, Baiguoyuan Group's ownership stake in Baiguoyuan Commercial Management will be diluted from 100% to 51.02% [1] - Baiguoyuan Commercial Management will continue to be a subsidiary of Baiguoyuan Group, and its financial performance will still be consolidated into the financial statements of the company [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 Shenzhen Pagoda Industrial (Group) Corporation Limited 深圳百果園實業 ( 集 團 ) 股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2411） 關連交易 (1) 視作出售一家附屬公司股權 及 (2) 於視作出售後 向一家關連附屬公司提供財務資助 獨立董事委員會及獨立股東的 獨立財務顧問 視作出售一家附屬公司的股權 於二零二六年二月二日，本公司訂立增資協議，據此田先生及賴先生同意各自 以代價每股股份人民幣1.0元，分別以現金向百果園商業管理的註冊股本出資人 民幣660,000元及人民幣300,000元。於注資完成後，田先生及賴先生將分別持 有百果園商業管理的約33.67%及15.31%股權。本公司於百果園商業管理的持股 比例將由100%攤薄至51.02%，而百果園商業管理將繼續為本公司的附屬公司， 且其財務業績將繼續併入本公司 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司證券的邀請或要約。 Shenzhen Pagoda Industrial (Group) Corporation Limited 深圳百果園實業 ( 集 團 ) 股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2411） 公告 建議更新現有一般授權 鑒於現有一般授權已動用大部分，董事會建議更新現有一般授權，以供其發 行不超過於通過該決議案當日本公司已發行股份總數20%之新股份。由於建 議更新現有一般授權乃於本公司下屆年度股東會前進行，故根據上市規則第 13.36(4)條，建議更新現有一般授權須於臨時股東會上獲獨立股東以特別決議 案方式批准。 一般事項 由全體獨立非執行董事組成的獨立董事委員會已經設立，以就建議更新現有一 般授權向獨立股東提供意見。本公司已委任第九資本有限公司為獨立財務顧 問，以就建議更新現有一般授權向獨立董事委員會及獨立 ...

Core Viewpoint - The collaboration between the government of Pujiang County and Baiguoyuan aims to promote the ecological agriculture of Pujiang Papaya, enhancing its market presence and quality through the introduction of advanced agricultural techniques [1][2] Group 1: Agricultural Development - Pujiang County has a planting area of 450,000 acres for Papaya, with an annual production exceeding 850,000 tons and a total output value surpassing 3.8 billion yuan [1] - The county's green development strategy includes the "two replacements" project, which promotes organic fertilizers over chemical fertilizers and green pest control over chemical methods, aiming for a zero pesticide, zero fertilizer, and zero hormone cultivation model [1] - Baiguoyuan has committed to not selling Papaya treated with sweeteners, ensuring consumer health and industry integrity [1] Group 2: Technological Integration - Baiguoyuan will introduce its BLOF ecological planting technology to improve the quality and safety of Papaya, which has recently been selected as a key agricultural technology by the Ministry of Agriculture and Rural Affairs for 2025 [2] - The partnership aims to leverage Baiguoyuan's brand, channels, and supply chain advantages to enhance the competitive edge of Pujiang's ecological agricultural resources [2] Group 3: Market Strategy - The selling price of Pujiang Papaya at Baiguoyuan is between 8 to 10 yuan per pound, with potential discounts during promotional events [2] - The collaboration is expected to create a full-chain traceability system, ensuring consumers can trust the quality of the products [2] - Baiguoyuan aims to establish itself as a leading platform for brand development, contributing to rural revitalization [2]

Core Viewpoint - The government of Pujiang County in Sichuan, in collaboration with Baiguoyuan, is promoting the launch of Pujiang Yaba Gan through a marketing event in Beijing, emphasizing the support for ecological agriculture [1] Group 1: Collaboration and Initiatives - Pujiang County and Baiguoyuan are jointly advocating for the initiative "Buy Pujiang Yaba Gan, Support Ecological Agriculture" [1] - The collaboration aims to enhance the quality and safety of the fruit by introducing Baiguoyuan's BLOF ecological planting technology [1] Group 2: Market Position and Supply Chain - Pujiang County has been a core production area for Baiguoyuan's Yaba Gan, with approximately 50% of Baiguoyuan's annual procurement volume sourced from the local area [1]

Core Insights - The 2026 Beijing Commercial Brand Conference and the announcement of the 2025 Top Ten Commercial Brands took place in Beijing, focusing on the theme "New Demand, New Supply" [1] - The event highlighted the importance of continuous innovation in business models to meet diverse consumer needs and promote high-quality industry development [1] Group 1: Main Awards - The "2025 Top Ten Commercial Brands" represents brands with significant market influence and leadership in industry development [4] - The ten brands awarded as "2025 Beijing Commercial Model Innovation Brands" include Baiguoyuan, Chaoyang Heshenghui, Hongqiao Market, Jitu Express, Nanxin Warehouse, Sam's Club, Xiaobai, Xidan Joy City, Yonghui Supermarket, and Yili [1][4] - The event introduced three new special award categories: "2025 Financial Product Innovation Empowering Consumption Excellent Cases," "Beijing Cultural, Business, Tourism, and Sports Integration Excellent Cases," and "Beijing Fashion Consumption Power Leading Brands" [4] Group 2: Subcategories - Four permanent subcategories were established: "2025 Beijing Commercial Quality Service Brands," "2025 Beijing Commercial Model Innovation Brands," "2025 Beijing Commercial Craftsmanship Brands," and "2025 Beijing Commercial New Star Brands" [4] - The focus on innovation and self-reform among awarded brands is aimed at uncovering new business models to satisfy increasingly diverse consumer demands [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 深圳百果園實業（集團）股份有限公司 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 H | | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02411 | 說明 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 1,818,837,500 | RMB | | 1 RMB | | 1,818,837,500 | | 增加 / 減少 (-) | | 181,883,750 | | | RMB | | 181,883,750 | | 本月底結存 | | 2,000,721,250 | RMB | | 1 RMB | | 2,000,721,250 | 本月底法定/註冊股本總額： RM ...

Group 1 - China Merchants Securities maintains an "Accumulate" rating for JD Health (06618.HK), highlighting its "medicine + pharmacy" dual-driven model and leading market share in retail pharmacies, with O2O delivery times as fast as 9 minutes [1] - China Everbright Securities International maintains an "Accumulate" rating for Biren Technology (06082.HK), noting its position as the first company in China to use 2.5D chip packaging technology and its strong commercial progress with over 2 billion yuan in unfulfilled orders [1] - Huachuang Securities maintains a "Strong Buy" rating for Hesai Technology (02525.HK), emphasizing its leadership in the global LiDAR market and significant cost reductions achieved through self-developed chips, with a delivery target of 200,000 units by 2025 [1] Group 2 - CICC maintains an "Outperform" rating for Haidilao (06862.HK), reporting stable table turnover rates in H2 and better-than-expected cost optimization, with new brand strategies accelerating growth [2] - CICC maintains an "Outperform" rating for Shuangdeng Co. (06960.HK), identifying it as a leader in communication and data center energy storage, benefiting from increased capital expenditure in global AIDC and the trend of lithium battery replacing lead-acid [2] Group 3 - CITIC Securities maintains a "Buy" rating for Kintor Group (00148.HK), noting the positive impact of price increases on its CCL business and the expected growth in PCB business volume [3] - CITIC Securities maintains a "Buy" rating for Shougang Resources (00639.HK), highlighting its resource scarcity and leading cost control, with expected performance growth amid rising coking coal prices in 2026-27 [3] - Shenwan Hongyuan maintains a "Buy" rating for Beautiful Garden Medical Health (02373.HK), emphasizing its accelerated industry consolidation through acquisitions and a significant increase in store numbers [3] - China Merchants Securities maintains an "Accumulate" rating for Baiguoyuan Group (02411.HK), noting its stock incentive plan and strategic upgrades aimed at restoring same-store growth and opening pace [3]

Core Viewpoint - The company has announced a stock incentive plan and a management shareholding increase plan, which are expected to enhance long-term incentive and constraint mechanisms, attract talent, and demonstrate confidence in long-term business development [1][2]. Group 1: Stock Incentive Plan - The company announced a stock incentive plan on December 1, 2025, granting 150 million restricted stock units to 14 employees, representing approximately 8.27% of the total issued shares [2]. - The grant price for the stock incentive is set at HKD 1.8 per share, with a vesting date of April 30, 2029 [2]. - The plan aims to align the interests of the recipients with those of the company and shareholders, linking vesting conditions to performance assessments at both company and individual levels [2]. Group 2: Management Shareholding Increase - The controlling shareholder, Mr. Yu Huiyong, plans to increase his shareholding by up to 10 million H shares within the next 12 months, currently holding 736 million H shares, which is about 36.8% of the company's total issued shares [1]. - This shareholding increase reflects the controlling shareholder's long-term confidence in the company's development [1]. Group 3: Investment Outlook - The company is currently in a strategic adjustment phase, actively promoting strategic upgrades to support long-term growth, with expectations of gradually restoring same-store sales growth and increasing store openings [3]. - Due to anticipated pressures on store openings and same-store performance in 2025, the company has adjusted its net profit forecasts for 2025, 2026, and 2027 to -360 million, 20 million, and 70 million respectively, maintaining an "Accumulate" investment rating [3].

Core Viewpoint - The report from China Merchants Securities upgrades the rating of Baiguoyuan Group (02411) to "Buy," highlighting the company's stock incentive plan and management's share buyback plan as measures to enhance long-term motivation and attract talent, reflecting confidence in the company's long-term development [1][2]. Group 1: Shareholder Actions - The controlling shareholder, Yu Huiyong, plans to increase his stake in the company by purchasing up to 10 million H-shares within the next 12 months, currently holding 736 million H-shares, which represents approximately 36.8% of the company's total issued shares, indicating strong long-term confidence in the company's growth [1]. Group 2: Equity Incentive Plan - The company announced an equity incentive plan on December 1, 2025, granting 150 million restricted stock units to 14 employees, equivalent to about 8.27% of the total issued shares, with a grant price of HKD 1.8 per share and a vesting date of April 30, 2029, aimed at aligning the interests of employees with those of the company and shareholders [2]. - The vesting conditions are tied to performance assessments at both the company and individual levels, including business growth and key performance indicators, with provisions for forfeiture in cases of significant misconduct [2].